Microbiome and cancer immunotherapies

Haoyan Chen; Laurence Zitvogel; Zhi Peng; Xiaochen Yin; Florencia McAllister

doi:10.1016/j.xcrm.2024.101514

Microbiome and cancer immunotherapies

Haoyan Chen, Laurence Zitvogel, Zhi Peng, Xiaochen Yin, Florencia McAllister

Research output: Contribution to journal › Comment/debate

Abstract

Here, we present 3 different perspectives on how the microbiome has impacted cancer patients, treatment, and clinical studies. We hear about the challenges of implementing microbiome analyses into the clinics, the impact these analyses might have on patients’ care, and treatment in the future, specifically for gastric cancer treatment. These are a few of the many voices that are highlighting the role of the microbiome in cancer development, treatment, and clinical outcomes.

Original language	English
Article number	101514
Journal	Cell Reports Medicine
Volume	5
Issue number	4
DOIs	https://doi.org/10.1016/j.xcrm.2024.101514
Publication status	Published - 16 Apr 2024

Access to Document

10.1016/j.xcrm.2024.101514

Cite this

@article{3d986896ff204eb1b61ba74b2f312834,

title = "Microbiome and cancer immunotherapies",

abstract = "Here, we present 3 different perspectives on how the microbiome has impacted cancer patients, treatment, and clinical studies. We hear about the challenges of implementing microbiome analyses into the clinics, the impact these analyses might have on patients{\textquoteright} care, and treatment in the future, specifically for gastric cancer treatment. These are a few of the many voices that are highlighting the role of the microbiome in cancer development, treatment, and clinical outcomes.",

author = "Haoyan Chen and Laurence Zitvogel and Zhi Peng and Xiaochen Yin and Florencia McAllister",

note = "Publisher Copyright: {\textcopyright} 2024",

year = "2024",

month = apr,

day = "16",

doi = "10.1016/j.xcrm.2024.101514",

language = "English",

volume = "5",

journal = "Cell Reports Medicine",

issn = "2666-3791",

number = "4",

}

TY - JOUR

T1 - Microbiome and cancer immunotherapies

AU - Chen, Haoyan

AU - Zitvogel, Laurence

AU - Peng, Zhi

AU - Yin, Xiaochen

AU - McAllister, Florencia

PY - 2024/4/16

Y1 - 2024/4/16

N2 - Here, we present 3 different perspectives on how the microbiome has impacted cancer patients, treatment, and clinical studies. We hear about the challenges of implementing microbiome analyses into the clinics, the impact these analyses might have on patients’ care, and treatment in the future, specifically for gastric cancer treatment. These are a few of the many voices that are highlighting the role of the microbiome in cancer development, treatment, and clinical outcomes.

AB - Here, we present 3 different perspectives on how the microbiome has impacted cancer patients, treatment, and clinical studies. We hear about the challenges of implementing microbiome analyses into the clinics, the impact these analyses might have on patients’ care, and treatment in the future, specifically for gastric cancer treatment. These are a few of the many voices that are highlighting the role of the microbiome in cancer development, treatment, and clinical outcomes.

UR - http://www.scopus.com/inward/record.url?scp=85189964821&partnerID=8YFLogxK

U2 - 10.1016/j.xcrm.2024.101514

DO - 10.1016/j.xcrm.2024.101514

M3 - Comment/debate

AN - SCOPUS:85189964821

SN - 2666-3791

VL - 5

JO - Cell Reports Medicine

JF - Cell Reports Medicine

IS - 4

M1 - 101514

ER -

Microbiome and cancer immunotherapies

Abstract

Access to Document

Other files and links

Cite this